Located within the Biotechnology unit at the University of Turku — a hub for in vitro diagnostics (IVD) innovation — the ICDx project benefits from a strong scientific foundation and innovative atmosphere.

The support from Business Finland enables the ICDx team to advance its scientific discoveries toward market readiness by conducting proof-of-concept studies, engaging with industry stakeholders, and building a clear commercialization strategy.

By bridging the gap between university-based innovation and industry needs, the project aims to bring high-impact diagnostic tools from the lab to real-world healthcare and wellness applications.